These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 10736239
1. Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester. Bjørn SF, Hastrup N, Larsen JF, Lund LR, Pyke C. Placenta; 2000; 21(2-3):170-6. PubMed ID: 10736239 [Abstract] [Full Text] [Related]
2. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus). Uekita T, Yamanouchi K, Sato H, Tojo H, Seiki M, Tachi C. Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196 [Abstract] [Full Text] [Related]
3. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H. Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249 [Abstract] [Full Text] [Related]
4. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y. Cancer Res; 1997 May 15; 57(10):2055-60. PubMed ID: 9158005 [Abstract] [Full Text] [Related]
5. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy. Bai SX, Wang YL, Qin L, Xiao ZJ, Herva R, Piao YS. Reproduction; 2005 Jan 15; 129(1):103-13. PubMed ID: 15615902 [Abstract] [Full Text] [Related]
6. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y. Am J Pathol; 1999 Feb 15; 154(2):417-28. PubMed ID: 10027400 [Abstract] [Full Text] [Related]
7. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Jo M, Thomas LE, Wheeler SE, Curry TE. Biol Reprod; 2004 Apr 15; 70(4):1024-32. PubMed ID: 14668206 [Abstract] [Full Text] [Related]
8. Interleukin-10 may participate in regulating trophoblast invasion in human placentae throughout gestation. Pang ZJ, Zhou JG, Huang LP. Am J Reprod Immunol; 2008 Jul 15; 60(1):19-25. PubMed ID: 18593434 [Abstract] [Full Text] [Related]
9. Co-ordinated expression of MMP-2 and its putative activator, MT1-MMP, in human placentation. Bjørn SF, Hastrup N, Lund LR, Danø K, Larsen JF, Pyke C. Mol Hum Reprod; 1997 Aug 15; 3(8):713-23. PubMed ID: 9294857 [Abstract] [Full Text] [Related]
10. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers. Théret N, Musso O, L'Helgoualc'h A, Campion JP, Clément B. Am J Pathol; 1998 Sep 15; 153(3):945-54. PubMed ID: 9736043 [Abstract] [Full Text] [Related]
11. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN. J Pathol; 2000 Jul 15; 191(3):245-56. PubMed ID: 10878545 [Abstract] [Full Text] [Related]
12. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland. Szabova L, Yamada SS, Birkedal-Hansen H, Holmbeck K. J Cell Physiol; 2005 Oct 15; 205(1):123-32. PubMed ID: 15895410 [Abstract] [Full Text] [Related]
13. MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-alpha levels. Hiden U, Glitzner E, Ivanisevic M, Djelmis J, Wadsack C, Lang U, Desoye G. Diabetes; 2008 Jan 15; 57(1):150-7. PubMed ID: 17928399 [Abstract] [Full Text] [Related]
14. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M, Risberg B, Kristensen GB, Tropé CG, Kopolovic J, Reich R. Am J Clin Pathol; 2001 Apr 15; 115(4):517-24. PubMed ID: 11293899 [Abstract] [Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K, Shigemasa K, Nagai N, Ohama K. Int J Oncol; 2000 Oct 15; 17(4):673-81. PubMed ID: 10995877 [Abstract] [Full Text] [Related]
16. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR. Br J Cancer; 1999 Apr 15; 79(11-12):1828-35. PubMed ID: 10206300 [Abstract] [Full Text] [Related]
17. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. Kitagawa Y, Kunimi K, Ito H, Sato H, Uchibayashi T, Okada Y, Seiki M, Namiki M. J Urol; 1998 Oct 15; 160(4):1540-5. PubMed ID: 9751409 [Abstract] [Full Text] [Related]
18. Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis. Hayashi K, Horikoshi S, Osada S, Shofuda K, Shirato I, Tomino Y. J Pathol; 2000 Jul 15; 191(3):299-305. PubMed ID: 10878552 [Abstract] [Full Text] [Related]
19. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells. Ohnishi Y, Tajima S, Ishibashi A. Eur J Dermatol; 2001 Jul 15; 11(5):420-3. PubMed ID: 11525948 [Abstract] [Full Text] [Related]
20. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Määttä M, Soini Y, Liakka A, Autio-Harmainen H. Clin Cancer Res; 2000 Jul 15; 6(7):2726-34. PubMed ID: 10914717 [Abstract] [Full Text] [Related] Page: [Next] [New Search]